Biotronik DFH Unipolar PE-60/4-DFH
510(k) K833106
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK833106 | Date20 Oct 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Biotronik DFH Unipolar PE-60/4-DFH is a Permanent Pacemaker Electrode, classified as a Class III device under FDA regulations. This unipolar electrode is designed for implantation in the cardiovascular system to deliver pacing stimuli, supporting cardiac rhythm management in patients requiring chronic pacing therapy.
This device is intended for single-use implantation and is supplied sterile. It is regulated under FDA 510(k) clearance (K833106) and falls under the product code DTB. The electrode is intended for use in a clinical setting by trained healthcare professionals, adhering to standard sterile procedures for pacemaker lead implantation. No MRI safety information or reusable specifications are provided in the data.
Other devices from Biotronik Sales, Inc.
Questions
AI-generated answers, 18 Sep 2026
Is this pacemaker electrode designed for reuse in multiple patients, or is it intended for single-use only?
The Biotronik DFH Unipolar PE-60/4-DFH is explicitly intended for single-use implantation only. The device is supplied sterile, which aligns with single-use medical devices meant to be implanted in a single patient to avoid contamination risks. Reuse is not supported or documented in the provided specifications.
What types of storage conditions are recommended for this device before implantation?
Since the device is supplied sterile and intended for single-use, it should be stored in its original packaging under controlled conditions to maintain sterility. While exact storage details (e.g., temperature, humidity) aren’t specified, standard sterile medical device storage practices—such as keeping it in a clean, dry environment away from direct sunlight—are advised. Always follow manufacturer instructions if additional guidance is provided.
Can this electrode be used with any pacemaker system, or is it compatible only with specific Biotronik devices?
The Biotronik DFH Unipolar PE-60/4-DFH is designed as a permanent pacemaker electrode for use in Biotronik’s pacing systems, but compatibility specifics (e.g., pacemaker models) aren’t detailed in the provided data. Clinicians should verify compatibility with their chosen pacemaker system by consulting Biotronik’s technical documentation or support resources, as electrode-pacemaker pairing is critical for safe and effective cardiac rhythm management.
How do I know if this device is the correct size for my patient’s anatomy?
The model name PE-60/4-DFH includes a 60 cm length designation, which is a key sizing parameter for pacemaker leads. The ‘4’ may refer to the electrode’s design (e.g., tines or fixation mechanism), but exact anatomical fit depends on the patient’s venous anatomy and implantation site. Clinicians should measure the patient’s venous pathway pre-procedure and confirm the lead’s length and fixation type align with their needs, as improper sizing can affect pacing performance or lead stability.
What should I consider when handling this device to ensure sterility is maintained during implantation?
The device is supplied sterile, so it must be handled using aseptic techniques throughout the procedure. This includes keeping the packaging intact until immediate use, avoiding contamination (e.g., touching the electrode with gloved hands), and adhering to sterile field protocols during implantation. Since it’s single-use, any breach of sterility—such as improper packaging handling—would invalidate the device for use, requiring replacement with a new sterile unit.